Go to content

Impact of the COVID-19 pandemic on prostate specific antigen testing and prostate cancer diagnosis in Ontario, Canada

Project ID: 2021-906/ TRIM 2022 0970 296 000

Principle Investigator: Robert Nam

Description: The aim of the current study is to compare prostate specific antigen (PSA) screening rates for prostate cancer before and during the pandemic. Among men diagnosed with prostate cancer, we will compare PSA levels at diagnosis, time from biopsy to definitive treatment, as well as prostate cancer grade and stage before versus during the pandemic. Among men who undergo biopsy, time from PSA to biopsy will be compared.

PIA approved: February 22, 2022